✦ LIBER ✦

Gene Therapy With Alipogene Tiparvovec Results in Enhanced Post-prandial Clearance of Chylomicrons in LPLD Patients

✍ Scribed by Gaudet, D.; Frisch, F.; Méthot, J.; Gagné, C.; Déry, S.; Tremblay, K.; de Wal, J.; Twisk, J.; Brisson, D.; Carpentier, A.C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

8 ALIPOGENE TIPARVOVEC GENE THERAPY ENHA

✍ Carpentier, A.C.; Frisch, F.; Labbé, S.M.; Méthot, J.; Gagné, C.; Déry, S.; Trem 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

L7 RESULTS OF FIRST FOLLOW UP STUDY WITH

✍ Gaudet, D.; de Wal, J.; Brisson, D.; van den Bulk, N.; Greentree, S.; Méthot, J. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

557 Alipogene Tiparvovec Gene Therapy Re

✍ Marco J. Bruno; Mark Deakin; Philippe B. Ruszniewski; Nick V. Bulk; Janneke de W 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Pancreatitis in patients with lipoprotei

✍ Deakin, M.; De Wal, J.; Camozzi, C.; Bruno, M.; Ruszniewski, P.; Gaudet, D. 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 48 KB

4.P.207 L-thyroxin therapy enhances clea

✍ Grosskopf, I.; Charach, G.; Weintraub, M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 164 KB